Cloned (Comment) | Organism |
---|---|
cloned from a brain cDNA library, stable overexpression of V5/His-tagged enzyme in HEK-293 cells | Rattus norvegicus |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
(1R, 2R)-2-(N-tetradecanoylamino)-1-(4-nitrophenyl)-1,3-propanediol | inhibits in vitro | Homo sapiens | |
(1S,2R)-D-erythro-2-(N-myristoylamino)-1-phenyl-1-propanol | inhibits in vitro | Homo sapiens | |
5-chloro-N-hexyl-2,4-dioxo-pyrimidine-1-carboxamide | - |
Homo sapiens | |
5-chloro-N-hexyl-2,4-dioxo-pyrimidine-1-carboxamide | - |
Rattus norvegicus | |
5-trifluoromethyl-N-hexyl-2,4-dioxo-pyrimidine-1-carboxamide | - |
Homo sapiens | |
5-trifluoromethyl-N-hexyl-2,4-dioxo-pyrimidine-1-carboxamide | - |
Rattus norvegicus | |
carmofur | a drug used in treatment of colorectal cancers and a potent in vivo active inhibitor of intracellular acid ceramidase activity. The potent noncompetitive inhibitor enzyme inhibitor has is anti-proliferative effects. Carmofur inhibits acid ceramidase and increases ceramide levels in human SW403 and LNCaP cells | Homo sapiens | |
carmofur | a drug used in treatment of human colorectal cancers and a potent noncompetitive inhibitor in vivo active inhibitor of intracellular acid ceramidase activity | Rattus norvegicus | |
additional information | modifications in the chemical scaffold of carmofur yield acid ceramidase inhibitors that act synergistically with standard antitumoral drugs to prevent cancer cell proliferation, design of chemosensitizing agents, overview | Homo sapiens | |
N-hexyl-2,4-dioxo-pyrimidine-1-carboxamide | - |
Homo sapiens | |
N-hexyl-2,4-dioxo-pyrimidine-1-carboxamide | - |
Rattus norvegicus | |
N-hexyl-5-methyl-2,4-dioxo-pyrimidine-1-carboxamide | - |
Homo sapiens | |
N-hexyl-5-methyl-2,4-dioxo-pyrimidine-1-carboxamide | - |
Rattus norvegicus | |
oleoylethanolamide | i.e. N-oleylethanolamine, inhibits in vitro | Homo sapiens |
KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
additional information | - |
additional information | Michaelis-Menten kinetics | Rattus norvegicus |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
N-acylsphingosine + H2O | Homo sapiens | the carboxylate is a fatty acid | carboxylate + sphingosine | - |
? | |
N-acylsphingosine + H2O | Rattus norvegicus | the carboxylate is a fatty acid | carboxylate + sphingosine | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | Q13510 | - |
- |
Rattus norvegicus | Q6P7S1 | - |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
brain | - |
Rattus norvegicus | - |
colorectal cancer cell | - |
Homo sapiens | - |
head and neck carcinoma cell | - |
Homo sapiens | - |
LNCaP cell | - |
Homo sapiens | - |
melanoma cell | - |
Homo sapiens | - |
additional information | acid ceramidase is abnormally expressed in various types of human cancer (e.g., prostate, head and neck, and colon) and serum enzyme levels are elevated in melanoma patients relative to control subjects | Homo sapiens | - |
prostate cancer cell | - |
Homo sapiens | - |
SW-403 cell | - |
Homo sapiens | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
N-acylsphingosine + H2O | the carboxylate is a fatty acid | Homo sapiens | carboxylate + sphingosine | - |
? | |
N-acylsphingosine + H2O | the carboxylate is a fatty acid | Rattus norvegicus | carboxylate + sphingosine | - |
? |
Synonyms | Comment | Organism |
---|---|---|
acid ceramidase | - |
Homo sapiens |
acid ceramidase | - |
Rattus norvegicus |
ASAH-1 | - |
Homo sapiens |
ASAH-1 | - |
Rattus norvegicus |
N-acylsphingosine amidohydrolase-1 | - |
Homo sapiens |
N-acylsphingosine amidohydrolase-1 | - |
Rattus norvegicus |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
0.000012 | - |
pH and temperature not specified in the publication | Rattus norvegicus | 5-trifluoromethyl-N-hexyl-2,4-dioxo-pyrimidine-1-carboxamide | |
0.000029 | - |
pH and temperature not specified in the publication | Rattus norvegicus | carmofur | |
0.000067 | - |
pH and temperature not specified in the publication | Rattus norvegicus | 5-chloro-N-hexyl-2,4-dioxo-pyrimidine-1-carboxamide | |
0.000426 | - |
pH and temperature not specified in the publication | Rattus norvegicus | N-hexyl-2,4-dioxo-pyrimidine-1-carboxamide | |
0.0015 | - |
pH and temperature not specified in the publication | Rattus norvegicus | N-hexyl-5-methyl-2,4-dioxo-pyrimidine-1-carboxamide |
General Information | Comment | Organism |
---|---|---|
malfunction | inhibition of acid ceramidase activity sensitizes tumor cells to the effects of antineoplastic agents and radiation | Rattus norvegicus |
malfunction | inhibition of acid ceramidase activity sensitizes tumor cells to the effects of antineoplastic agents and radiation. Carmofur inhibits acid ceramidase and increases ceramide levels in human SW403 and LNCaP cells | Homo sapiens |
physiological function | acid ceramidase is a cysteine amidase that hydrolyses the proapoptotic lipid ceramide, and is abnormally high in several human tumors, which is suggestive of a role in chemoresistance. The enzyme is involved in the regulation of ceramide levels in cells and modulates the ability of this lipid messenger to influence the survival, growth and death of tumor cells | Homo sapiens |
physiological function | acid ceramidase is a cysteine amidase that hydrolyses the proapoptotic lipid ceramide, and is abnormally high in several human tumors, which is suggestive of a role in chemoresistance. The enzyme is involved in the regulation of ceramide levels in cells and modulates the ability of this lipid messenger to influence the survival, growth and death of tumor cells | Rattus norvegicus |